Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang Su

Showing results (591-600 of 594) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 594 results.
Experimental Hematology & Oncology|November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumorsRongrui Liu, Rongbo Lin, Ning Li, et al.
Cancers|March 27, 2020
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung AdenocarcinomaLovely Raghav, Ya-Hsuan Chang, Yi-Chiung Hsu, et al.
JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.
Molecular Cancer|June 4, 2026
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancerYa-Hsuan Chang, Yi-Ju Chen, Zhi-Jie Hong, et al.
Pageof 60

Showing results (591-600 of 594) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 594 results.
Experimental Hematology & Oncology|November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumorsRongrui Liu, Rongbo Lin, Ning Li, et al.
Cancers|March 27, 2020
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung AdenocarcinomaLovely Raghav, Ya-Hsuan Chang, Yi-Chiung Hsu, et al.
JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.
Molecular Cancer|June 4, 2026
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancerYa-Hsuan Chang, Yi-Ju Chen, Zhi-Jie Hong, et al.
Pageof 60